Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard Yu

Showing results (51-60 of 56) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 56 results.
Cancer Cell|July 11, 2018
Bi-allelic Loss of CDKN2A Initiates Melanoma Invasion via BRN2 ActivationHanlin Zeng, Aparna Jorapur, A Hunter Shain, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 17, 2009
Phase III, randomized, open-label study of daily imatinib mesylate 400 mg versus 800 mg in patients with newly diagnosed, previously untreated chronic myeloid leukemia in chronic phase using molecular end points: tyrosine kinase inhibitor optimization and selectivity studyJorge E Cortes, Michele Baccarani, François Guilhot, et al.
Cancer Communications (London, England)|August 20, 2024
Concurrent chemoradiotherapyof different radiation doses and different irradiation fields for locally advanced thoracic esophageal squamous cell carcinoma: A randomized, multicenter, phase III clinical trialJian Zhang, Minghao Li, Kaixian Zhang, et al.
The Lancet. Oncology|February 4, 2021
Fertility preservation for male patients with childhood, adolescent, and young adult cancer: recommendations from the PanCareLIFE Consortium and the International Late Effects of Childhood Cancer Guideline Harmonization GroupRenée L Mulder, Anna Font-Gonzalez, Daniel M Green, et al.
Annals of the Rheumatic Diseases|September 28, 2022
Low copy numbers of complement <i>C4</i> and <i>C4A</i> deficiency are risk factors for myositis, its subgroups and autoantibodiesDanlei Zhou, Emily H King, Simon Rothwell, et al.
Hong Kong Medical Journal = Xianggang Yi Xue Za Zhi|December 9, 2003
Consensus statement on iodine deficiency disorders in Hong KongBetty But, C W Chan, Fredriech Chan, et al.
Pageof 6

Showing results (51-60 of 56) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 56 results.
Cancer Cell|July 11, 2018
Bi-allelic Loss of CDKN2A Initiates Melanoma Invasion via BRN2 ActivationHanlin Zeng, Aparna Jorapur, A Hunter Shain, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 17, 2009
Phase III, randomized, open-label study of daily imatinib mesylate 400 mg versus 800 mg in patients with newly diagnosed, previously untreated chronic myeloid leukemia in chronic phase using molecular end points: tyrosine kinase inhibitor optimization and selectivity studyJorge E Cortes, Michele Baccarani, François Guilhot, et al.
Cancer Communications (London, England)|August 20, 2024
Concurrent chemoradiotherapyof different radiation doses and different irradiation fields for locally advanced thoracic esophageal squamous cell carcinoma: A randomized, multicenter, phase III clinical trialJian Zhang, Minghao Li, Kaixian Zhang, et al.
The Lancet. Oncology|February 4, 2021
Fertility preservation for male patients with childhood, adolescent, and young adult cancer: recommendations from the PanCareLIFE Consortium and the International Late Effects of Childhood Cancer Guideline Harmonization GroupRenée L Mulder, Anna Font-Gonzalez, Daniel M Green, et al.
Annals of the Rheumatic Diseases|September 28, 2022
Low copy numbers of complement <i>C4</i> and <i>C4A</i> deficiency are risk factors for myositis, its subgroups and autoantibodiesDanlei Zhou, Emily H King, Simon Rothwell, et al.
Hong Kong Medical Journal = Xianggang Yi Xue Za Zhi|December 9, 2003
Consensus statement on iodine deficiency disorders in Hong KongBetty But, C W Chan, Fredriech Chan, et al.
Pageof 6